Motorcar Parts of America to Present At B. Riley Consumer Conference
Sep 20, 2017 12:01 pm UTC| Business
LOS ANGELES, Sept. 20, 2017 -- Motorcar Parts of America, Inc. (Nasdaq:MPAA) today announced it is scheduled to make a presentation on Thursday, September 28, 2017 at 2:30 p.m. Eastern time at the B. Riley Co. Consumer...
Lipocine Announces FDA Advisory Committee Meeting for TLANDO™
Sep 20, 2017 12:01 pm UTC| Business
SALT LAKE CITY, Sept. 20, 2017 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced that the Bone, Reproductive and Urologic Drugs Advisory Committee (“BRUDAC”) of the U.S. Food and Drug...
Carpenter to Increase Prices on All Stainless Steel Product Forms
Sep 20, 2017 12:01 pm UTC| Business
PHILADELPHIA, Sept. 20, 2017 -- Carpenter Technology Corporation (NYSE:CRS) announced today that it will increase base prices three percent (3%) to eight percent (8%) on new non-contract orders across all stainless...
Umpqua Holdings Corporation Names Dave Shotwell Chief Risk Officer
Sep 20, 2017 12:01 pm UTC| Business
PORTLAND, Ore., Sept. 20, 2017 -- Umpqua Holdings Corporation (NASDAQ:UMPQ), parent company of Umpqua Bank and Umpqua Investments, announced today that Dave Shotwell has been named Umpqua Bank’s first chief risk...
Auris Medical to Present at the LEERINK Partners Rare Disease Roundtable Series on September 27
Sep 20, 2017 12:01 pm UTC| Business
ZUG, Switzerland, Sept. 20, 2017 -- Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in otolaryngology, today announced that...
Benevity Data Shows 2016 Election Cycle Kicked Off Major Shift in Corporate Giving Trends
Sep 20, 2017 12:01 pm UTC| Business
CALGARY, Sept. 20, 2017 -- Benevity, the market leader in workplace giving, volunteering and community investment software, announced today the release of new data showing a significant shift in charitable donation...
Altimmune Announces its Phase 2 Flu Vaccine Trial with NasoVAX Open for Enrollment
Sep 20, 2017 12:01 pm UTC| Business
60 Patients to be enrolledData expected in the first quarter of 2018 GAITHERSBURG, Md., Sept. 20, 2017 -- Altimmune, Inc. (Nasdaq:ALT), a clinical-stage immunotherapeutics company, today announced that they have been...